Nusli Wadia Raises Concerns Over Tata Chemicals' Overseas Investment
Mumbai: Continued investments by Tata Chemicals in under-performing overseas business incurring substantial losses, specially in the UK, have led to destruction of shareholder value with net debt of the firm rising to Rs 8,695 crore in the last 10 years, according to Nusli Wadia.
Facing a shareholders' vote on December 23 after Tata Sons moved a resolution to remove him as an independent director of Tata Chemicals, Mr Wadia also said the series of allegations against him were "totally false and baseless".
"I had raised my serious concerns over the years for providing continuing financial resources of the company towards the overseas business and assets, which were continuously under performing and incurring substantial losses," he wrote in a letter to the shareholders of the company.
Highlighting the 2005 acquisition of Brunner Mond Group, he said, "I as well as some other board members expressed serious apprehensions on the proposal for the acquisition of Brunner Mond Group, having soda ash business operations in UK, Kenya (Magadi Soda) and the Netherlands at a cost of around Rs 800 crore for sound reasons."
However, decision was ultimately taken by consensus, he added.
"Unfortunately shortly after the acquisition the profitability became negative and continued to remain so...This has now led to an impairment on this acquisition of approximately Rs 1,600 crore," Mr Wadia wrote.
The company is currently looking to extricate itself from substantial part of its UK business, including the pension fund issues, which it has inherited from the acquisition.
"The investment and their costs have led to the destruction of shareholder value of your company," he said while seeking their support against the move by Tata Sons to oust him as an Independent director, which he has been for the past 35 years.
Highlighting flaws in the inorganic expansion approach of the company, Mr Wadia said: "During the last ten years mainly due to various acquisitions, the consolidated debt of your company went up from Rs 1,827 crore to Rs 8,695 crore, an increase of Rs 6,800 crore."
This included the funding required for other joint ventures and subsidiaries. The total impairment of all the various investments made is approximately Rs 2,000 crore, he added.
Reacting to a series of allegations made by Tata Sons against him, Mr Wadia said: "...that I am acting against the interests of Tata Chemicals is totally false and baseless. I have served as an Independent director of Tata Chemicals for the past 35 years as also Chairman of the Nomination and Remuneration Committee where at the Annual General Meeting I am answerable to shareholders."
On the allegations that he is 'galvanising Independent directors and mobilising opinion, forcing disruptions and issuing statement which is contrary to the interests of the Company', Mr Wadia said these "are totally baseless and completely unsubstantiated."
Mr Wadia also claimed that the statement issued by the Independent directors of Tata Chemicals on November 10, "affirming confidence in the Board, Chairman and the management in the conduct of the company's business was a unanimous statement".
Stressing that he had carried out his duty as an Independent Director, Mr Wadia also said he "differed strongly" with Ratan Tata in the merger of then Hindustan Lever Chemicals Ltd (HLCL) and Tata Chemicals in 2003.
Taking a dig at the cross holdings of Tata Chemicals in various Tata group listed and unlisted firms, Mr Wadia claimed the approximate value of the unlisted shares is around Rs 7,200 crore or more.
"The current value of the listed shares is in excess of around Rs 1,300 crore making a total of around Rs 8,500 crore.
If these holdings were to be disposed off, your company would be debt free. These cross holdings are being maintained in a debt ridden company only to indirectly keep the voting rights and control in Tata Sons," Mr Wadia said.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.